J. Schlegel

发表

Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission

Jennifer Schlegel, D. DeRyckere, D. Graham, 2013, Journal of Hematology & Oncology.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

C. Miller, S. Frye, A. Tan, 2013, The Journal of clinical investigation.

Endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor synthesis

F. Schade, H. Brade, J. Schlegel, 1996 .

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, H. Martinson, 2013, Oncogene.

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia

D. DeRyckere, D. Graham, S. Christoph, 2013, Blood Cancer Journal.

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, H. Martinson, 2013, Oncogene.

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

D. DeRyckere, D. Graham, J. Schlegel, 2012, PloS one.

Solution Characterization of the Extracellular Region of CD147 and Its Interaction with Its Enzyme Ligand Cyclophilin A

R. Hodges, E. Eisenmesser, W. Labeikovsky, 2009, Journal of Molecular Biology.

Characterizing and controlling the inherent dynamics of cyclophilin‐A

E. Eisenmesser, J. Redzic, Fengli Zhang, 2009, Protein science : a publication of the Protein Society.

Formation of a TNF synthesis inhibitor in endotoxin tolerance.

F. Schade, E. Rietschel, J. Schlegel, 1995, Progress in clinical and biological research.

UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo

S. Frye, W. Janzen, H. Earp, 2013, Molecular Cancer Therapeutics.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

C. Miller, S. Frye, J. M. Shields, 2013, The Journal of clinical investigation.

UNC 569 , a novel small molecule Mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo

S. Frye, W. Janzen, H. Earp, 2013 .

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia

H. Earp, S. Hunsucker, D. DeRyckere, 2016, Oncogene.